Clinical Trial Update: Dialysis Performance of the FX CorAL Membrane [NA]

View source ↗

Summary

A completed clinical trial evaluated the dialysis performance of the FX CorAL membrane. The study was sponsored by University Hospital Ghent.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Snippet

Sponsor: University Hospital, Ghent | Conditions: Hemodialysis Complication, Anticoagulants | NA | Status: COMPLETED